Citius Oncology (CTOR) Prepaid Assets (2022 - 2026)

Citius Oncology (CTOR) has 5 years of Prepaid Assets data on file, last reported at $3.1 million in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 13.05% year-over-year to $3.1 million in Q1 2026; TTM through Mar 2026 was $3.1 million, a 13.05% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 50.69% from the prior year.
• Prepaid Assets for Q1 2026 stood at $3.1 million, down from $3.2 million in the prior quarter.
• Over the last five years, Prepaid Assets for CTOR reached as high as $7.7 million in Q3 2023 and fell as low as $25454.0 in Q4 2023.
• Historically, Prepaid Assets has averaged $1.8 million across 5 years, with a median of $1.2 million in 2025.
• Across the five-year window, Prepaid Assets sank 71.13% in 2023 and jumped 10507.37% in 2024, its largest moves.
• Year by year, Prepaid Assets stood at $88169.0 in 2022, then sank by 71.13% to $25454.0 in 2023, then soared by 10507.37% to $2.7 million in 2024, then grew by 17.15% to $3.2 million in 2025, then retreated by 3.5% to $3.1 million in 2026.
• Per Business Quant data, the three most recent Prepaid Assets figures were $3.1 million in Q1 2026, $3.2 million in Q4 2025, and $1.3 million in Q3 2025.